Literature DB >> 6801105

Spontaneous hypothyroidism after antithyroid treatment of hyperthyroid Graves' disease.

B A Lamberg, J Salmi, G Wägar, T Mäkinen.   

Abstract

Out of 54 patients with hyperthyroid Graves' disease 35 remained euthyroid after treatment with antithyroid agents and have been continuously followed from 1 to 9 yr (4.85 +/- 2.55 yr, mean +/- SD). In 4 patients an exaggerated TSH response to TRH developed from 30 to 111 months after interrupting the treatment and one of them became hypothyroid 50 months (5.0 yr) thereafter. The annual incidence of subclinical hypothyroidism (exaggerated response to TRH) as calculated from the total number of observation yr was 2.5% and that of overt hypothyroidism was 0.6%. These figures are similar to those reported recently in 2 retrospective studies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6801105     DOI: 10.1007/BF03348302

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  The natural history of hyperthyroidism due to Graves' disease in remission: sequential studies of pituitary-thyroid regulation and various serum parameters.

Authors:  D F Gardner; R D Utiger
Journal:  J Clin Endocrinol Metab       Date:  1979-09       Impact factor: 5.958

2.  The thyro-hypophysial syndrome. IV. Hypophysial eye signs (including exophthalmos) without thyrotoxicosis (solitary thyro-hypophysial syndrome) and their treatment by roentgen irradiation of the pituitary region.

Authors:  B A LAMBERG
Journal:  Acta Med Scand       Date:  1957-01-15

3.  Hyperophthalmopathic Graves' disease.

Authors:  J H MEANS
Journal:  Ann Intern Med       Date:  1945-11       Impact factor: 25.391

4.  Thyroid-stimulating immunoglobulins in Graves' disease.

Authors:  B R Smith; R Hall
Journal:  Lancet       Date:  1974-08-24       Impact factor: 79.321

5.  On the effect of thyrotropin and immunoglobulins related to Graves' disease on thyrotropin synthesis and secretion.

Authors:  P Dandona; D J El Kabir
Journal:  Clin Endocrinol (Oxf)       Date:  1978-10       Impact factor: 3.478

6.  Serum thyrotrophin and circulating thyroglobulin and thyroid microsomal antibodies in a Finnish population.

Authors:  A Gordin; J Maatela; A Miettinen; T Helenius; B A Lamberg
Journal:  Acta Endocrinol (Copenh)       Date:  1979-01

7.  Ophthalmopathy associated with primary hypothyroidism.

Authors:  B E Brownlie; O A Newton; S P Singh
Journal:  Acta Endocrinol (Copenh)       Date:  1975-08

8.  Primary hypothyroidism preceding thyrotoxicosis: a report of 2 cases and a review of the literature.

Authors:  W J Irvine; B A Lamberg; D R Cullen; R Gordin
Journal:  J Clin Lab Immunol       Date:  1979-11

9.  Grades of hypothyroidism.

Authors:  D C Evered; B J Ormston; P A Smith; R Hall; T Bird
Journal:  Br Med J       Date:  1973-03-17

10.  Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.

Authors:  K Endo; K Kasagi; J Konishi; K Ikekubo; T Okuno; Y Takeda; T Mori; K Torizuka
Journal:  J Clin Endocrinol Metab       Date:  1978-05       Impact factor: 5.958

View more
  3 in total

Review 1.  An update on the medical treatment of Graves' hyperthyroidism.

Authors:  Michele Marinò; Francesco Latrofa; Francesca Menconi; Luca Chiovato; Paolo Vitti
Journal:  J Endocrinol Invest       Date:  2014-09-04       Impact factor: 4.256

2.  Comparison of RA 131I treatment protocols for Graves' disease.

Authors:  L J DeGroot; A Mangklabruks; M McCormick
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

3.  Conversion of Primary Hypothyroidism to Hyperthyroidism: A Case Report.

Authors:  Liam Clifford; Ammar Wakil
Journal:  J ASEAN Fed Endocr Soc       Date:  2018-11-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.